Events & Presentations
Upcoming Webcasts
No webcasts scheduled. Check back soon.
Webcast Archive
-
AMT-130 Huntington’s Disease Program Update
View Webcast -
uniQure AMT-130 Program Update
View Webcast
8:30 a.m. -
Guggenheim Genomic Medicines & Rare Disease Day
View Webcast
8:00 a.m. ET / 2:00 p.m. CET
Investor Presentations
-
AMT-130 12-Month Low-Dose Cohort Update – Investor Webcast Presentation
View Presentation -
EAHAD 2022 – Final Analysis from the Pivotal Phase 3 HOPE-B Gene Therapy Trial: Stable Steady-State Efficacy and Safety of Etranacogene Dezaparvovec in Adults with Severe or Moderately Severe Hemophilia B
View Presentation -
2021 Dutch Statutory IFRS Financials
View Presentation -
ISTH 2021 – Clinical Outcomes in Adults with Hemophilia B With Pre-existing Neutralizing Antibodies to AAV5: 6 Month Data from the HOPE-B Trial
View Presentation -
Gene Therapy Information
View Presentation